Taqieddin Ehab, Amiji Mansoor
Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, 110 Mugar Life Sciences Building, Boston, MA 02115, USA.
Biomaterials. 2004 May;25(10):1937-45. doi: 10.1016/j.biomaterials.2003.08.034.
Alginate-chitosan core-shell microcapsules were prepared in order to develop a biocompatible matrix for enzyme immobilization, where the protein is retained either in a liquid or solid core and the shell allows permeability control over substrates and products. The permeability coefficients of different molecular weight compounds (vitamin B2, vitamin B12, and myoglobin) were determined through sodium tripolyphosphate (Na-TPP)-crosslinked chitosan membrane. The microcapsule core was formed by crosslinking sodium alginate with either calcium or barium ions. The crosslinked alginate core was uniformly coated with a chitosan layer and crosslinked with Na-TPP. In the case of calcium alginate, the phosphate ions of Na-TPP were able to extract the calcium ions from alginate and liquefy the core. A model enzyme, beta-galactosidase, was immobilized in the alginate core and the catalytic activity was measured with o-nitrophenyl-beta-D-galactopyranoside (ONPG). Change in the activity of free and immobilized enzyme was determined at three different temperatures. Na-TPP crosslinked chitosan membranes were found to be permeable to solutes of up to 17,000Da molecular weight. The enzyme loading efficiency was higher in the barium alginate core (100%) as compared to the calcium alginate core (60%). The rate of ONPG conversion to o-nitrophenol was faster in the case of calcium alginate-chitosan microcapsules as compared to barium alginate-chitosan microcapsules. Barium alginate-chitosan microcapsules, however, did improve the stability of the enzyme at 37 degrees C relative to calcium alginate-chitosan microcapsules or free enzyme. This study illustrates a new method of enzyme immobilization for biotechnology applications using liquid or solid core and shell microcapsule technology.
制备了藻酸盐-壳聚糖核壳微胶囊,以开发一种用于酶固定化的生物相容性基质,其中蛋白质保留在液体或固体核中,而壳允许对底物和产物进行渗透性控制。通过三聚磷酸钠(Na-TPP)交联的壳聚糖膜测定了不同分子量化合物(维生素B2、维生素B12和肌红蛋白)的渗透系数。微胶囊核是通过藻酸钠与钙或钡离子交联形成的。交联的藻酸盐核均匀地涂覆有壳聚糖层,并与Na-TPP交联。在藻酸钙的情况下,Na-TPP的磷酸根离子能够从藻酸盐中提取钙离子并使核液化。将一种模型酶β-半乳糖苷酶固定在藻酸盐核中,并用邻硝基苯基-β-D-吡喃半乳糖苷(ONPG)测量催化活性。在三个不同温度下测定游离酶和固定化酶活性的变化。发现Na-TPP交联的壳聚糖膜对分子量高达17,000Da的溶质具有渗透性。与藻酸钙核(60%)相比,藻酸钡核中的酶负载效率更高(100%)。与藻酸钡-壳聚糖微胶囊相比,藻酸钙-壳聚糖微胶囊中ONPG转化为邻硝基苯酚的速率更快。然而,相对于藻酸钙-壳聚糖微胶囊或游离酶,藻酸钡-壳聚糖微胶囊确实提高了酶在37℃下的稳定性。本研究说明了一种利用液体或固体核壳微胶囊技术进行酶固定化的新方法,用于生物技术应用。